Lawrence D. Recht

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]

Michael Glantz, Bernard F. Cole, Peter Forsyth et al. · Neurology · 2000 · 850 citations · Full text

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

Michael Glantz, Kurt A. Jaeckle, Marc C. Chamberlain et al. · PubMed · 1999 · 526 citations

Neuro-oncology, Surgical Oncology, Medicine +13

Cerebrospinal fluid cytology in patients with cancer

Michael Glantz, Bernard F. Cole, Lisa Glantz et al. · Cancer · 1998 · 448 citations · Full text

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study

James M. Schuster, R. K. Lai, Lawrence D. Recht et al. · Neuro-Oncology · 2015 · 406 citations · Full text